Fusen Pharmaceutical Company Limited (1652.HK)
HKD 0.81
(-2.41%)
HKD 0.81
(-2.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 565.6 Million | 491.75 Million | 385.66 Million | 486.85 Million | 407.38 Million | 462.06 Million |
| Cost of Revenue | 266.1 Million | 266.73 Million | 174.53 Million | 220.78 Million | 194.9 Million | 210.74 Million |
| Gross Profit | 299.5 Million | 225.02 Million | 211.13 Million | 266.06 Million | 212.48 Million | 251.31 Million |
| Operating Expenses | 279.49 Million | 186.41 Million | 146.64 Million | 181.83 Million | 166.1 Million | 127.7 Million |
| Selling, General and Administrative Expenses | 214.43 Million | 188.64 Million | 156.18 Million | 186.28 Million | 171.53 Million | 138.89 Million |
| Research and Development Expenses | 65.19 Million | 15.37 Million | 10.64 Million | 27.27 Million | 11.6 Million | 11.22 Million |
| Other Expenses | -15.93 Million | -2.22 Million | -9.53 Million | -4.45 Million | -5.42 Million | 983 Thousand |
| Cost and Expenses | 545.59 Million | 453.15 Million | 321.17 Million | 402.61 Million | 361 Million | 338.45 Million |
| Operating Income | 20.01 Million | 15.73 Million | 52.13 Million | 103.21 Million | 66.14 Million | 136.06 Million |
| Interest Expense | 12.58 Million | 12.38 Million | 8.24 Million | 9.43 Million | 9.19 Million | 15.59 Million |
| Income Tax Expense | 6.84 Million | 3.66 Million | 7.17 Million | 15.73 Million | 11.55 Million | 21.9 Million |
| Earnings before Tax | -29.44 Million | -30.99 Million | 23.79 Million | 78.4 Million | 63.81 Million | 123.81 Million |
| Net Income | -36.27 Million | -34.65 Million | 16.64 Million | 70.13 Million | 53.43 Million | 101.88 Million |
| Earnings Per Share Basic | -0.05 | -0.05 | 0.02 | 0.09 | 0.07 | 0.15 |
| Earnings Per Share Diluted | -0.05 | -0.05 | 0.02 | 0.09 | 0.07 | 0.15 |
| Weighted Average Shares Outstanding | 725.54 Million | 756.07 Million | 769.62 Million | 786.07 Million | 800 Million | 694.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 752.05 Million | 756.07 Million | 770.31 Million | 790.16 Million | 802.94 Million | 694.79 Million |
| Gross Margin | 0.53 | 0.46 | 0.55 | 0.55 | 0.52 | 0.54 |
| EBIT Margin | 0.03 | 0.10 | 0.23 | 0.26 | 0.18 | 0.31 |
| Profit Margin | -0.06 | -0.07 | 0.04 | 0.14 | 0.13 | 0.22 |
| EBITDA | 18.93 Million | 49.89 Million | 86.83 Million | 110.29 Million | 75.35 Million | 144.74 Million |
| Earnings Before Tax Margin | 0.04 | 0.03 | 0.14 | 0.21 | 0.16 | 0.29 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 98.16 Million | 98.16 Million | 114.58 Million | 565.6 Million | 114.58 Million | 168.21 Million |
| Cost of Revenue | 45.22 Million | 45.22 Million | 54.39 Million | 266.1 Million | 54.39 Million | 78.65 Million |
| Gross Profit | 52.93 Million | 52.93 Million | 60.19 Million | 299.5 Million | 60.19 Million | 89.55 Million |
| Operating Expenses | 71.2 Million | 71.2 Million | 69.58 Million | 271.45 Million | 82.55 Million | 75.84 Million |
| Selling, General and Administrative Expenses | 44.21 Million | 44.21 Million | 37.78 Million | - | 37.78 Million | 69.43 Million |
| Research and Development Expenses | 28.52 Million | 28.52 Million | 28.47 Million | - | 28.47 Million | 12.01 Million |
| Other Expenses | -1.54 Million | -1.54 Million | 3.32 Million | -3.28 Million | - | - |
| Cost and Expenses | 116.43 Million | 116.43 Million | 123.97 Million | 537.55 Million | 136.94 Million | 154.5 Million |
| Operating Income | -18.26 Million | -18.26 Million | -9.39 Million | 20.01 Million | -8.67 Million | 19.4 Million |
| Interest Expense | - | - | - | 12.58 Million | - | 3.38 Million |
| Income Tax Expense | 4.18 Million | 4.18 Million | 199 Thousand | 6.84 Million | 199 Thousand | 3.22 Million |
| Earnings before Tax | -22.66 Million | -22.66 Million | -26.17 Million | -29.44 Million | -26.17 Million | 11.44 Million |
| Net Income | -18.47 Million | -18.47 Million | -26.36 Million | -36.27 Million | -26.36 Million | 8.22 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.04 | - | -0.04 | 0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.04 | - | -0.04 | 0.01 |
| Weighted Average Shares Outstanding | 738.82 Million | 738.82 Million | 749.21 Million | 725.54 Million | 749.21 Million | 822.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 740.67 Million | 740.67 Million | 749.21 Million | 752.05 Million | 749.21 Million | 754.9 Million |
| Gross Margin | 0.54 | 0.54 | 0.53 | 0.53 | 0.53 | 0.53 |
| EBIT Margin | -0.10 | -0.10 | -0.01 | - | -0.01 | 0.15 |
| Profit Margin | -0.19 | -0.19 | -0.23 | -0.06 | -0.23 | 0.05 |
| EBITDA | -9.76 Million | -9.76 Million | -1.11 Million | - | -1.11 Million | 25.89 Million |
| Earnings Before Tax Margin | -0.19 | -0.19 | -0.08 | 0.04 | -0.08 | 0.12 |
EPSOMPRO
CODAF
TINNATFL
BTPN
BHB
3696